iSpecimen® Increases Global Access to Hematopoietic Stem and Immune Cells
Summary
LEXINGTON, Mass.--(BUSINESS WIRE)--Devoted to supporting life science researchers who urgently pursue breakthroughs, iSpecimen today announced it has partnered with new providers of diseased and healthy hematologic tissue to offer one of the industry’s largest, most integrated networks of donors and collection sites available while addressing proliferating demand for hematopoietic stem and immune cell products. The iSpecimen Marketplace also offers the industry’s most comprehensive donor screening capability, permitting researchers to select the required scope of infectious disease testing such as CMV, hepatitis (B&C), HIV, West Nile Virus, syphilis, Chagas, and more. “ Hematopoietic stem and immune cells are used in some of the newest and most exciting medical science occurring today,” said Wayne Vaz, Vice President of Growth and Corporate Development. There is a clear market trend towards increasing supply chain efficiency while maintaining a high level of regulatory compliance, data integrity, product selection, speed, and scalability. Proprietary cloud-based technology enables researchers to intuitively search for specimens and patients across a federated partner network of hospitals, labs, biobanks, blood centers, and other healthcare organizations.